Response to: A Phase III open-label, randomized, active controlled clinical study to assess safety, immunogenicity and lot-to-lot consistency of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants

被引：0

作者：

Gillard, P. ^{[1
]}

Benninghoff, B. ^{[1
]}

机构：

[1] GlaxoSmithKline, Ave Fleming 20, B-1300 Wavre, Belgium

来源：

VACCINE | 2019年 / 37卷 / 23期

关键词：

RIX4414;

D O I：

10.1016/j.vaccine.2019.04.003

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：2990 / 2990

页数：1

共 50 条

[1] A Phase III open-label, randomized, active controlled clinical study to assess safety, immunogenicity and lot-to-lot consistency of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants
Rathi, Niraj
Desai, Sajjad
Kawade, Anand
Venkatramanan, Padmasani
Kundu, Ritabrata
Lalwani, Sanjay K.
Dubey, A. P.
Rao, J. Venkateswara
Narayanappa, D.
Ghildiyal, Radha
Gogtay, Nithya
Venugopal, P.
Palkar, Sonali
Munshi, Renuka
Kang, Gagandeep
Babji, Sudhir
Bavdekar, Ashish
Juvekar, Sanjay
Ganguly, Nupur
Niyogi, Prabal
Uttam, Kheya Ghosh
Rajani, H. S.
Kondekar, Alpana
Kumbhar, Dipti
Mohanlal, Smilu
Agarwal, Mukesh C.
Shetty, Parvan
Antony, Kalpana
Gunale, Bhagwat
Dharmadhikari, Abhijeet
Tang, Yuxiao
Kulkarni, Prasad S.
Flores, Jorge
VACCINE, 2018, 36 (52) : 7943 - 7949
[2] Immunogenicity and lot-to-lot consistency of a ready to use liquid bovine-human reassortant pentavalent rotavirus vaccine (ROTASIIL - Liquid) in Indian infants
Kawade, Anand
Babji, Sudhir
Kamath, Veena
Raut, Abhishek
Kumar, Chandra Mohan
Kundu, Ritabrata
Venkatramanan, Padmasani
Lalwani, Sanjay K.
Bavdekar, Ashish
Juvekar, Sanjay
Dayma, Girish
Patil, Rakesh
Kulkarni, Muralidhar
Hegde, Asha
Nayak, Dinesh
Garg, B. S.
Gupta, Subodh
Jategaonkar, Smita
Bedi, Nidhi
Maliye, Chetna
Ganguly, Nupur
Uttam, Kheya Ghosh
Niyogi, Prabal
Palkar, Sonali
Hanumante, Neeta
Goyal, Nidhi
Arya, Alok
Aslam, Mohd.
Paruiekar, Varsha
Dharmadhikari, Abhijeet
Gaikwad, Dutta
Zade, Jagdish
Desai, Sajjad
Kang, Gagandeep
Kulkarni, Prasad S.
VACCINE, 2019, 37 (19) : 2554 - 2560
[3] A randomized Phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants
Kulkarni, Prasad S.
Desai, Sajjad
Tewari, Tushar
Kawade, Anand
Goyal, Nidhi
Garg, Bishan Swarup
Kumar, Dinesh
Kanungo, Suman
Kamat, Veena
Kang, Gagandeep
Bavdekar, Ashish
Babji, Sudhir
Juvekar, Sanjay
Manna, Byomkesh
Dutta, Shanta
Angurana, Rama
Dewan, Deepika
Dharmadhikari, Abhijeet
Zade, Jagdish K.
Dhere, Rajeev M.
Fix, Alan
Power, Maureen
Uprety, Vidyasagar
Parulekar, Varsha
Cho, Iksung
Chandola, Temsunaro R.
Kedia, Vikash K.
Raut, Abhishek
Flores, Jorge
VACCINE, 2017, 35 (45) : 6228 - 6237
[4] Safety, immunogenicity and lot-to-lot consistency of a new Bivalent Oral Polio Vaccine (bOPV) in healthy Infants: Results of a Phase III, observer blind, randomized, controlled clinical study
Zaman, Khalequ
Kingma, Robert
Yunus, Md
van Straaten, Ineke
Mekkes, Dirk
Bouwstra, Xandra
Gunale, Bhagwat
Kulkarni, Prasad S.
VACCINE, 2019, 37 (31) : 4275 - 4280
[5] Safety, immunogenicity, and lot-to-lot consistency of a quadrivalent inactivated influenza vaccine in children, adolescents, and adults: A randomized, controlled, phase III trial
Cadorna-Carlos, Josefina B.
Nolan, Terry
Borja-Tabora, Charissa Fay
Santos, Jaime
Montalban, M. Cecilia
de Looze, Ferdinandus J.
Eizenberg, Peter
Hall, Stephen
Dupuy, Martin
Hutagalung, Yanee
Pepin, Stephanie
Saville, Melanie
VACCINE, 2015, 33 (21) : 2485 - 2492
[6] Lot-to-lot consistency, safety and immunogenicity of 3 lots of Haemophilus influenzae type b conjugate vaccine: results from a phase III randomized, multicenter study in infants
Klein, Nicola P.
Abu-Elyazeed, Remon
Cornish, Matthew
Leonardi, Michael L.
Weiner, Leonard B.
Silas, Peter E.
Grogg, Stanley E.
Varman, Meera
Frenck, Robert W.
Cheuvart, Brigitte
Baine, Yaela
Miller, Jacqueline M.
Leyssen, Maarten
Mesaros, Narcisa
Roy-Ghanta, Sumita
VACCINE, 2017, 35 (28) : 3564 - 3574
[7] Immunogenicity and safety of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine (PRV) in Indian infants
Lokeshwar, M. R.
Bhave, Sheila
Gupta, Ashok
Goyal, V. K.
Walia, Anuj
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2013, 9 (01) : 172 - 176
[8] Safety, immunogenicity and lot-to-lot consistency of a new Bivalent Oral Polio Vaccine (bOPV) in healthy Infants: Results of a Phase III, observer blind, randomized, controlled clinical study (vol 37, pg 4275, 2019)
Zaman, Khalequ
Kingma, Robert
Yunus, Md
van Straaten, Ineke
Mekkes, Dirk
Bouwstra, Xandra
Gunale, Bhagwat
Kulkarni, Prasad S.
VACCINE, 2020, 38 (03) : 707 - 708
[9] Safety, Immunogenicity and Lot-to-Lot Consistency of Sabin-Strain Inactivated Poliovirus Vaccine in 2-Month-Old Infants: A Double-Blind, Randomized Phase III Trial
Zheng, Yan
Ying, Zhifang
Zou, Yanxiang
Zhu, Taotao
Qian, Dinggu
Han, Weixiao
Jiang, Ya
Jiang, Zhiwei
Li, Xingyan
Wang, Jianfeng
Lei, Jin
Xu, Li
Jiang, Deyu
Li, Changgui
Liu, Xiaoqiang
VACCINES, 2022, 10 (02)
[10] Safety, immunogenicity, and lot-to-lot consistency of a split-virion quadrivalent influenza vaccine in younger and older adults: A phase III randomized, double-blind clinical trial
Sesay, Sanie
Brzostek, Jerzy
Meyer, Ingo
Donazzolo, Yves
Leroux-Roels, Geert
Rouzier, Regine
Astruc, Beatrice
Szymanski, Henryk
Toursarkissian, Nicole
Vandermeulen, Corinne
Kowalska, Edyta
Van Damme, Pierre
Salamand, Camille
Pepin, Stephanie
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (03) : 596 - 608

← 1 2 3 4 5 →